CO2024002786A2 - Métodos y composiciones para tratar el cáncer - Google Patents
Métodos y composiciones para tratar el cáncerInfo
- Publication number
- CO2024002786A2 CO2024002786A2 CONC2024/0002786A CO2024002786A CO2024002786A2 CO 2024002786 A2 CO2024002786 A2 CO 2024002786A2 CO 2024002786 A CO2024002786 A CO 2024002786A CO 2024002786 A2 CO2024002786 A2 CO 2024002786A2
- Authority
- CO
- Colombia
- Prior art keywords
- compositions
- methods
- treating cancer
- scc
- treating
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 3
- 206010041823 squamous cell carcinoma Diseases 0.000 abstract 3
- 201000000744 recessive dystrophic epidermolysis bullosa Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/28—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163232409P | 2021-08-12 | 2021-08-12 | |
| PCT/US2022/040092 WO2023018891A1 (en) | 2021-08-12 | 2022-08-11 | Methods and compositions for treating cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO2024002786A2 true CO2024002786A2 (es) | 2024-03-18 |
Family
ID=85200519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CONC2024/0002786A CO2024002786A2 (es) | 2021-08-12 | 2024-03-06 | Métodos y composiciones para tratar el cáncer |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240299326A1 (https=) |
| EP (1) | EP4384498A1 (https=) |
| JP (1) | JP2024531238A (https=) |
| CN (1) | CN118076583A (https=) |
| AU (1) | AU2022326485A1 (https=) |
| CA (1) | CA3228644A1 (https=) |
| CO (1) | CO2024002786A2 (https=) |
| GB (1) | GB2628229A (https=) |
| IL (1) | IL310759A (https=) |
| MX (1) | MX2024001935A (https=) |
| WO (1) | WO2023018891A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5156389B2 (ja) * | 2005-01-05 | 2013-03-06 | テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション | 薬剤耐性増殖性疾患の治療剤 |
| WO2014089483A1 (en) * | 2012-12-07 | 2014-06-12 | Onconova Therapeutics, Inc. | Methods and compositions for treatment of cancer |
| JP2018530590A (ja) * | 2015-10-14 | 2018-10-18 | タリックス ファーマシューティカルズ リミテッド | 表皮水疱症の処置のための方法及び組成物 |
| CA3076610A1 (en) * | 2017-09-22 | 2019-03-28 | University Of Miami | Methods and compositions for the treatment of epidermolysis bullosa |
-
2022
- 2022-08-11 CA CA3228644A patent/CA3228644A1/en active Pending
- 2022-08-11 JP JP2024508686A patent/JP2024531238A/ja active Pending
- 2022-08-11 MX MX2024001935A patent/MX2024001935A/es unknown
- 2022-08-11 WO PCT/US2022/040092 patent/WO2023018891A1/en not_active Ceased
- 2022-08-11 AU AU2022326485A patent/AU2022326485A1/en active Pending
- 2022-08-11 IL IL310759A patent/IL310759A/en unknown
- 2022-08-11 GB GB2402730.2A patent/GB2628229A/en active Pending
- 2022-08-11 EP EP22856622.0A patent/EP4384498A1/en active Pending
- 2022-08-11 CN CN202280068270.9A patent/CN118076583A/zh active Pending
-
2024
- 2024-02-09 US US18/437,793 patent/US20240299326A1/en active Pending
- 2024-03-06 CO CONC2024/0002786A patent/CO2024002786A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023018891A1 (en) | 2023-02-16 |
| US20240299326A1 (en) | 2024-09-12 |
| GB2628229A (en) | 2024-09-18 |
| AU2022326485A1 (en) | 2024-02-29 |
| MX2024001935A (es) | 2024-03-21 |
| GB202402730D0 (en) | 2024-04-10 |
| CA3228644A1 (en) | 2023-02-16 |
| CN118076583A (zh) | 2024-05-24 |
| WO2023018891A8 (en) | 2023-09-21 |
| IL310759A (en) | 2024-04-01 |
| JP2024531238A (ja) | 2024-08-29 |
| EP4384498A1 (en) | 2024-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20210401A1 (es) | Composiciones farmaceuticas que comprenden meloxicam | |
| CO2021010415A2 (es) | Inhibidor jak y método de preparación del mismo | |
| PY2146661A (es) | Compuestos para el tratamiento de enfermedades y trastornos asociados a braf | |
| WO2020102804A3 (en) | Pharmaceutical combination for treatment of cancer | |
| FI3849534T3 (fi) | Yhdistelmähoidot | |
| CO2019015090A2 (es) | Métodos de tratamiento para la fibrosis cística | |
| MX2025000105A (es) | Inhibidor de kras g12c para el tratamiento del cancer | |
| EP4306523A3 (en) | Imidazoquinoline compounds and uses thereof | |
| MX2023003332A (es) | Inhibidores del elemento 1 interdispersado largo (line-1) para el tratamiento de enfermedades. | |
| MX2021013980A (es) | Compuesto para el tratamiento de gota o hiperuricemia. | |
| IL314873A (en) | Compositions and methods for treating disorders ameliorated by muscarnic receptor activation | |
| ECSP18051143A (es) | Formulaciones de 2-(4-clorofenil)-n-((2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolin-5-il)metil)-2,2-difluoroacetamida | |
| AR114216A1 (es) | Composiciones oftálmicas de compuestos de bencimidazol para uso único diario | |
| JP2016502981A5 (https=) | ||
| WO2006083979B1 (en) | Local treatment of neurofibromas | |
| CO2024002786A2 (es) | Métodos y composiciones para tratar el cáncer | |
| AU2017261303A1 (en) | Ophthalmic compositions | |
| PE20181332A1 (es) | Metodos de sedacion y formulacion parenteral para uso durante el tratamiento de cuidados criticos | |
| MX2023011176A (es) | Tratamiento de hidradenitis supurativa con orismilast. | |
| MX2020010201A (es) | Conjugado de farmaco citotoxico y forma de profarmaco de dicho conjugado. | |
| MX2020004667A (es) | Compuestos, composiciones y metodos para el tratamiento de trastornos oculares y enfermedades cutaneas. | |
| BR112019005224A2 (pt) | forma de dosagem para alívio prolongado | |
| EA202092579A1 (ru) | Оксозамещенное соединение | |
| AR129959A1 (es) | Método para tratar enfermedades o trastornos orgánicos con inhibidores de ask1 | |
| EP4069251A4 (en) | SALTS AND POLYMORPHS OF CETHROMYCIN FOR THE TREATMENT OF DISEASES |